• Thumbnail for BioNTech
    "Prof. Christopher Huber". Biontech Biography. Biontech. Retrieved 5 August 2021. "SEC Filing | BioNTech". investors.biontech.de. p. 130. Retrieved 28 December...
    40 KB (3,683 words) - 06:40, 26 August 2024
  • Thumbnail for Pfizer–BioNTech COVID-19 vaccine
    The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, is an mRNA-based COVID-19 vaccine developed by the German biotechnology company...
    253 KB (21,778 words) - 18:59, 30 August 2024
  • Thumbnail for Operation Warp Speed
    at BioNTech's laboratories in Mainz, Germany, just days after the SARS-Cov-2 genetic sequence was first made public. In September 2020, BioNTech received...
    71 KB (5,902 words) - 06:09, 15 August 2024
  • Thumbnail for COVID-19 vaccination in Africa
    Bank to address the health and economic impact of COVID-19. Meanwhile, BioNTech and the European Union are collaborating to assess mRNA vaccine production...
    110 KB (11,862 words) - 22:35, 9 November 2023
  • Thumbnail for COVID-19 vaccination in Canada
    delivery schedule for Pfizer-BioNTech’s COVID-19 vaccine." By the end of September, Canada will receive the 40 million Pfizer-BioNTech doses. Major General Fortin...
    185 KB (14,787 words) - 04:28, 26 July 2024
  • Thumbnail for COVID-19 vaccination in South Africa
    approved the Pfizer-BioNTech vaccine for section 21 Emergency Use Authorisation. A trial ending in March 2021 of the Pfizer-BioNTech's COVID-19 vaccine appeared...
    198 KB (13,219 words) - 00:29, 16 August 2024
  • Thumbnail for MRNA vaccine
    Pfizer–BioNTech's BNT162b2 COVID-19 vaccine for widespread use. On 11 December, the FDA gave emergency use authorization for the Pfizer–BioNTech COVID-19...
    77 KB (7,879 words) - 16:49, 14 July 2024
  • Thumbnail for Katalin Karikó
    Katalin Karikó (category BioNTech)
    associated with BioNTech RNA Pharmaceuticals, first as a vice president and promoted to senior vice president in 2019. In 2022, she left BioNTech to devote...
    42 KB (4,538 words) - 08:52, 30 August 2024
  • regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin...
    319 KB (19,375 words) - 22:21, 17 July 2024
  • On 25 January 2021, the TGA provisionally approved the two-dose Pfizer–BioNTech COVID-19 vaccine, named COMIRNATY, for use within Australia. The provisional...
    23 KB (1,797 words) - 10:10, 9 August 2024
  • Thumbnail for COVID-19 vaccination in Taiwan
    agreements with Fosun Pharma to each purchase 5 million doses of the Pfizer-BioNTech COVID-19 vaccine. Combined, the two deals would include a total of 10 million...
    76 KB (6,546 words) - 20:42, 16 May 2024
  • Thumbnail for Özlem Türeci
    Özlem Türeci (category BioNTech)
    company BioNTech, which in 2020 developed the first messenger RNA-based vaccine approved for use against COVID-19. Türeci has served as BioNTech's chief...
    42 KB (3,520 words) - 04:23, 21 August 2024
  • Thumbnail for Pfizer
    and neurology. The company's largest products by sales are the Pfizer–BioNTech COVID-19 vaccine ($11 billion in 2023 revenues), apixaban ($6 billion in...
    167 KB (14,521 words) - 12:08, 29 August 2024
  • Thumbnail for Uğur Şahin
    Uğur Şahin (category BioNTech)
    oncologist, immunologist, and entrepreneur. He is the founder and CEO of BioNTech, which developed one of the major vaccines against COVID-19. His main fields...
    56 KB (6,117 words) - 04:41, 26 August 2024
  • Thumbnail for COVID-19 vaccination in Norway
    Pfizer-BioNTech vaccine. The children under 15 years old need parental approval to be vaccinated, and they only get 1 dose of the Pfizer-BioTech vaccine...
    7 KB (541 words) - 20:34, 16 May 2024
  • Thumbnail for COVID-19 vaccination in the United States
    Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, and mass vaccinations began four days later...
    134 KB (10,707 words) - 19:06, 19 July 2024
  • Thumbnail for COVID-19 vaccination in Indonesia
    274,950 doses of the Pfizer–BioNTech vaccine arrived in Indonesia. On 16 September, 2.5 million doses of the Pfizer–BioNTech vaccine and 968,360 doses of...
    133 KB (10,785 words) - 23:40, 4 July 2024
  • Thumbnail for History of COVID-19 vaccine development
    had been distributed for use outside of the phase 3 trial. The Pfizer–BioNTech partnership submitted an Emergency Use Authorization (EUA) request to the...
    122 KB (11,033 words) - 22:07, 17 July 2024
  • Thumbnail for 2020
    begin mass vaccination with the Pfizer–BioNTech COVID-19 vaccine. In addition, Singapore approves the Pfizer–BioNTech COVID-19 vaccine, with other companies...
    235 KB (19,273 words) - 05:39, 31 August 2024
  • weakened immune systems. Several COVID‑19 vaccines, such as the Pfizer–BioNTech and Moderna vaccines, use RNA to stimulate an immune response. When introduced...
    200 KB (22,829 words) - 00:35, 30 August 2024
  • Thumbnail for COVID-19 vaccination in Italy
    people and public service personnel should receive the vaccine. The Pfizer–BioNTech COVID-19 vaccine was authorized by the European Commission on 21 December...
    57 KB (3,437 words) - 04:40, 3 August 2024
  • Thumbnail for Deployment of COVID-19 vaccines
    multiple countries. Two of the first approved vaccines, Pfizer and BioNTech's Pfizer-BioNTech COVID‑19 vaccine and Moderna's mRNA-1273, must be kept cold during...
    156 KB (13,915 words) - 23:28, 12 August 2024
  • Thumbnail for COVID-19 vaccine misinformation and hesitancy
    study in the New England Journal of Medicine reported that the Pfizer–BioNTech COVID-19 vaccine was 88 percent effective in preventing symptomatic infections...
    132 KB (12,883 words) - 20:49, 30 August 2024
  • authorizations (EUA) to 10 COVID-19 vaccines (in chronological order): Pfizer–BioNTech, Oxford–AstraZeneca, Sinovac, Sputnik V, Janssen, Covaxin, Moderna, Sinopharm...
    128 KB (9,955 words) - 00:32, 16 August 2024
  • conditional and temporary authorization to supply for use of the Pfizer–BioNTech COVID-19 vaccine codenamed BNT162b2 (later branded as Comirnaty). This...
    24 KB (2,284 words) - 13:17, 26 June 2024
  • Thumbnail for COVID-19 pandemic in Bulgaria
    The COVID-19 pandemic in Bulgaria was a part of the worldwide pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome...
    300 KB (12,355 words) - 22:58, 28 August 2024
  • Thumbnail for COVID-19 vaccination in Bulgaria
    all seven vaccines included in the European portfolio - Moderna, Pfizer-BioNTech, Oxford–AstraZeneca, Sanofi, CureVac, Novavax, and Janssen, even though...
    453 KB (34,260 words) - 15:07, 13 June 2024
  • July 2021, BioNTech's Chinese sales agent Fosun Pharma announced that Foxconn and TSMC had reached an agreement to purchase 10 million BioNTech COVID-19...
    116 KB (9,754 words) - 05:58, 28 August 2024
  • Thumbnail for COVID-19 vaccination in Israel
    bodies of government. The state purchased a substantial amount of Pfizer–BioNTech COVID-19 vaccines relative to its population as early as December 2020...
    39 KB (3,352 words) - 02:55, 6 July 2024
  • Thumbnail for Albert Bourla
    Staphylococcus, Clostridioides difficile infection, infant diseases, and the Pfizer–BioNTech COVID-19 vaccine. Bourla opposes government interference in pharmaceutical...
    28 KB (2,367 words) - 23:07, 10 August 2024